Redox Regulation of the Nutrient-sensitive Raptor-mTOR Pathway and Complex
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
The raptor-mTOR protein complex is a key component of a nutrient-sensitive signaling pathway that regulates cell size by controlling the accumulation of cellular mass. How nutrients regulate signaling through the raptor-mTOR complex is not well known. Here we show that a redox-sensitive mechanism regulates the phosphorylation of the raptor-mTOR effector S6K1, the interaction between raptor and mTOR, and the kinase activity of the raptor-mTOR complex. In cells treated with the oxidizing agents diamide or phenylarsine oxide, S6K1 phosphorylation increased and became insensitive to nutrient deprivation. Conversely, the reducing reagent BAL (British anti-Lewisite, also known as 2,3-dimercapto-1-propanol) inhibits S6K1 phosphorylation and stabilizes the interaction of mTOR and raptor to mimic the state of the complex under nutrient-deprived conditions. Our findings suggest that a redox-based signaling mechanism may participate in regulating the nutrient-sensitive raptor-mTOR complex and pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cysteine oxidation enhances phosphorylation of S6K, which is a direct readout of mTORC1 activation”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [117]
In the citing paper
“treatment with reducing agents effectively suppresses mTORC1 activation via inhibition of S6K phosphorylation”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [117]
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Self-citationMorice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Kim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
Self-citationSarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Self-citationMammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,114
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00636-6 · Cited by 1,886
Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Self-citationChung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,150
Cited by
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
“A reducing environment inhibits mTORC1 possibly via a redox sensor in the FATC domain of mTOR (Dames et al., 2005; Sarbassov and Sabatini, 2005).”
BackgroundDefining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
“In contrast to growth-factor-driven activation of mTORC1, hypoxia, AMPK activation resulting from depletion of cellular energy, WNT-GSK3 signaling, and glucocorticoids all inhibit mTORC1 by promoting TSC1/2 activation (Inoki et al., 2006; Reiling and Sabatini, 2006; Wang et al., 2006).”
BackgroundInfluentialSelf-citationp53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326
“mTOR is redox sensitive (Dames et al., 2005; Sarbassov and Sabatini, 2005), and the Sestrins were reported to be involved in redox-mediated reactivation of peroxiredoxins (Budanov et al.”
Redox metabolism: ROS as specific molecular regulators of cell signaling and function
Lennicke, C., & Cochemé, H. M. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.018 · Cited by 1,246
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner
Kalender, A., Selvaraj, A., Kim, S. Y., Gulati, P., Brûlé, S., Viollet, B., Kemp, B. E., Bardeesy, N., Dennis, P., Schlager, J. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.014 · Cited by 889
“Given that glucose deprivation affects the interaction between raptor and mTOR and the kinase activity of the raptor-mTOR complex in a manner similar to amino acid withdrawal (Kim et al., 2002; Sarbassov and Sabatini, 2005), we reasoned that the Rag GTPases might be involved in the metformin inhibitory response.”
BackgroundInfluentialBhaskar, P. T., & Hay, N. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.03.020 · Cited by 798
Sch9 Is a Major Target of TORC1 in Saccharomyces cerevisiae
Urban, J., Soulard, A., Huber, A., Lippman, S., Mukhopadhyay, D., Deloche, O., Wanke, V., Anrather, D., Ammerer, G., Riezman, H., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.020 · Cited by 798
Zhou, H., S. Beevers, C., & Huang, S. (2011) · Current Drug Targets · doi:10.2174/138945011794815356 · Cited by 715
“mTOR also functions as a central sensor of cellular nutrient/amino acid levels [104,111,112], cellular energy status [111], cellular redox status [113], and mitogen stimulation, particularly from insulin, IGF-1, and IGF-2 [114,115].”
BackgroundStem cells and the impact of ROS signaling
Bigarella, C. L., Liang, R., & Ghaffari, S. (2014) · Development · doi:10.1242/dev.107086 · Cited by 632
“…of HSCs and NSCs in Atm −/− mice (Ito et al., 2004; Maryanovich et al., 2012) Mammalian target of rapamycin (mTOR) Activated by Cys oxidation (Sarbassov and Sabatini, 2005; Yoshida et al., 2011) mTOR overactivity increases mitochondrial biogenesis and ROS production (Chen et al., 2008)…”
BackgroundBerndt, S. I., Gustafsson, S., Mägi, R., Ganna, A., Wheeler, E., Feitosa, M. F., Justice, A. E., Monda, K. L., Croteau-Chonka, D. C., Day, F. R., et al. (2013) · Nature Genetics · doi:10.1038/ng.2606 · Cited by 646
Redox regulation of the immune response
Morris, G., Gevezova, M., Sarafian, V., & Maes, M. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-022-00902-0 · Cited by 575
Dreyer, H. C., Fujita, S., Cadenas, J. G., Chinkes, D. L., Volpi, E., & Rasmussen, B. B. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.113175 · Cited by 570
“In particular, the increased stabilization of the interaction between raptor and mTOR during nutrient deprivation or exposure to reducing agents is associated with an inactivation of mTOR (Kim et al. 2002; Sarbassov & Sabatini, 2005).”
BackgroundSignaling pathways controlling skeletal muscle mass
Egerman, M. A., & Glass, D. J. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.857291 · Cited by 555
“…downstream signaling through the phosphorylation and activation of p70S6K, and inhibition of 4E-BP1 (also called PHAS-1), with downstream targets including the ribosomal protein S6 (RPS6) and the eukaryotic translation initiator eIF4E (Sarbassov & Sabatini, 2005; Sarbassov et al., 2005) (Figure 1).”
BackgroundRegulation of macroautophagy by mTOR and Beclin 1 complexes
Pattingre, S., Espert, L., Biard-Piechaczyk, M., & Codogno, P. (2008) · Biochimie · doi:10.1016/j.biochi.2007.08.014 · Cited by 521
Complex interplay between autophagy and oxidative stress in the development of pulmonary disease
Ornatowski, W., Lu, Q., Yegambaram, M., Garcia, A. E., Zemskov, E. A., Maltepe, E., Fineman, J. R., Wang, T., & Black, S. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101679 · Cited by 467
Redox homeostasis: The Golden Mean of healthy living
Ursini, F., Maiorino, M., & Forman, H. J. (2016) · Redox Biology · doi:10.1016/j.redox.2016.01.010 · Cited by 415
“The condition of increased global energetic substrate availability inhibits AMPK [113] and sirtuins [114], the regulators of metabolic control of the fasting condition, while decreased nucleophilic tone also activates mTOR [115] as a typical metabolic adaptive reaction.”
BackgroundUpstream of the mammalian target of rapamycin: do all roads pass through mTOR?
Corradetti, M. N., & Guan, K.-L. (2006) · Oncogene · doi:10.1038/sj.onc.1209885 · Cited by 386
“Thiol oxidation also induces destabilization of the Raptor-mTOR interaction (Sarbassov and Sabatini, 2005), consistent with previous data that showed the Raptor-mTOR interaction is stabilized by mTOR inhibiting agents (Kim et al., 2002).”
ResultRedox control of senescence and age-related disease.
Chandrasekaran, A., Idelchik, M. D. P. S., & Melendez, J. A. (2017) · Redox Biology · doi:10.1016/j.redox.2016.11.005 · Cited by 360
Metabolic Reprogramming in Glioma
Strickland, M., & Stoll, E. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00043 · Cited by 345
“Structure and Function of mTOR mTOR integrates signaling from growth factor pathways with cellular energy and nutrient levels, co-ordinating this activity with biosynthetic machinery and cell cycle machinery (Sarbassov and Sabatini, 2005; Duzgun et al., 2016).”
BackgroundInfluentialActivation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
Perl, A. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.172 · Cited by 332
Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in Cancer Cells
Thedieck, K., Holzwarth, B., Prentzell, M. T., Boehlke, C., Kläsener, K., Ruf, S., Sonntag, A. G., Maerz, L., Grellscheid, S.-N., Kremmer, E., et al. (2013) · Cell · doi:10.1016/j.cell.2013.07.031 · Cited by 336
“This is in agreement with earlier studies (Sarbassov and Sabatini, 2005; Yoshida et al., 2011) reporting that oxidative stress disassembles mTORC1.”
Metastasis: cancer cell’s escape from oxidative stress
Pani, G., Galeotti, T., & Chiarugi, P. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9225-4 · Cited by 313
“Additionally, ROS may promote HIF activity by stimulating the mTOR/S6-kinase pathway [169, 170], either directly, through a putative redox switch located in the mTOR kinase [171], or indirectly via oxidative inhibition of PTEN [152].”
BackgroundReiling, J. H., & Sabatini, D. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209889 · Cited by 311
“Oxidant addition to cells decreased raptor binding to mTOR but increased S6K activity, which is dominant over leucine deprivation and inhibition of mitochondrial or glycolytic function (Sarbassov and Sabatini, 2005).”
BackgroundSelf-citationLeucine Deprivation Increases Hepatic Insulin Sensitivity via GCN2/mTOR/S6K1 and AMPK Pathways
Xiao, F., Huang, Z., Li, H., Yu, J., Wang, C., Chen, S., Meng, Q., Cheng, Y., Gao, X., Li, J., et al. (2011) · Diabetes · doi:10.2337/db10-1246 · Cited by 286
“Consistent with previous results (19), phosphorylation of these proteins was decreased by leucine deprivation in HepG2 cells (Fig.”
Lagoumtzi, S. M., & Chondrogianni, N. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.003 · Cited by 279
Fernandez, D. R., Telarico, T., Bonilla, E., Li, Q., Banerjee, S., Middleton, F. A., Phillips, P. E., Crow, M. K., Oess, S., Muller-Esterl, W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803600 · Cited by 257
“In accordance with previous findings (42), NOC-18 (300 M), which is capable of slowly releasing NO, and H2O2 (50 M) stimulated mTOR activity 5.”
ResultChen, L., Xu, B., Liu, L., Luo, Y., Zhou, H., Chen, W., Shen, T., Han, X., Kontos, C. D., & Huang, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.032 · Cited by 251
“In addition to Cd, other oxidative agents, such as diamide and phenylarsineoxide, have alsobeen found toactivatemTORsignaling [40].”
BackgroundRosner, M., & Hengstschlager, M. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn192 · Cited by 233
“For immunoprecipitation of mTOR complexes, total cellular protein was extracted as described in Sarbassov and Sabatini (74) to achieve maximum mTOR complex recovery.”
MethodCell growth control: little eukaryotes make big contributions
De Virgilio, C., & Loewith, R. (2006) · Oncogene · doi:10.1038/sj.onc.1209884 · Cited by 218
“Indeed, mammalian TOR (mTOR) has been suggested to respond to redox potential (Sarbassov and Sabatini, 2005).”
BackgroundPerl, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12756 · Cited by 218
The amino acid sensitive TOR pathway from yeast to mammals
Dann, S. G., & Thomas, G. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.068 · Cited by 213
“More recently, Sarbassov and Sabatini [100] reported that the raptor–mTOR interaction is a redox-sensitive event where reducing reagents result in more raptor bound to mTOR even in amino acid replete conditions.”
BackgroundCurcumin Disrupts the Mammalian Target of Rapamycin-Raptor Complex
Beevers, C. S., Chen, L., Liu, L., Luo, Y., Webster, N. J. G., & Huang, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2367 · Cited by 203
“It has been reported that oxidants are involved in the activation (50) or inactivation (3) of mTOR signaling.”
The coordination of nuclear and mitochondrial communication during aging and calorie restriction
Finley, L. W. S., & Haigis, M. C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.03.003 · Cited by 207
“Changes in redox state can also affect the stability of the mTOR complex, with oxidizing agents increasing phosphorylation of S6K1 by mTOR (Sarbassov and Sabatini, 2005).”
BackgroundRedox Control of Skeletal Muscle Regeneration
Le Moal, E., Pialoux, V., Juban, G., Groussard, C., Zouhal, H., Chazaud, B., & Mounier, R. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6782 · Cited by 195
“These effects can be explained by a higher activation of the mTOR pathway, the master regulator of cell growth and protein synthesis previously described as a redox-regulated molecule (294) and of PGC-1 a (171), the master regulator of oxidative metabolism (191, 196).”
Mechanisms of mitochondria and autophagy crosstalk
Rambold, A. S., & Lippincott-Schwartz, J. (2011) · Cell Cycle · doi:10.4161/cc.10.23.18384 · Cited by 189
Perl, A., Hanczko, R., Lai, Z.-W., Oaks, Z., Kelly, R., Borsuk, R., Asara, J. M., & Phillips, P. E. (2015) · Metabolomics · doi:10.1007/s11306-015-0772-0 · Cited by 189
“9). mTOR complex 1 (mTORC1), which was measured here via phosphorylation of its downstream substrate, pS6RP, is stimulated by oxidative stress (Sarbassov and Sabatini 2005) and the lysosomal accumulation of amino acids (Bar-Peled et al. 2013).”
BackgroundThe interplay between autophagy and ROS in tumorigenesis
Kongara, S., & Karantza, V. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00171 · Cited by 184
Yu, X., & Long, Y. C. (2016) · Scientific Reports · doi:10.1038/srep30033 · Cited by 170
The Role of Reactive Oxygen Species in the Life Cycle of the Mitochondrion
Venditti, P., & Di Meo, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062173 · Cited by 170
Kim, S. K., & Novak, R. F. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.07.004 · Cited by 167
“Rictor is a rapamycin-insensitive companion of mTOR and defines a distinct pathway regulating PKCα and Akt signaling (Sarbassov and Sabatini, 2005).”
BackgroundRedox homeostasis, oxidative stress and mitophagy
Garza-Lombó, C., Pappa, A., Panayiotidis, M. I., & Franco, R. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.01.002 · Cited by 160
Yoshida, S., Hong, S., Suzuki, T., Nada, S., Mannan, A. M., Wang, J., Okada, M., Guan, K.-L., & Inoki, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238014 · Cited by 156
Joseph, G. A., Wang, S. X., Jacobs, C. E., Zhou, W., Kimble, G. C., Tse, H. W., Eash, J. K., Shavlakadze, T., & Glass, D. J. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00141-19 · Cited by 158
“The mTORC1 complex induces downstream signaling responsible for protein synthesis through phosphorylation and activation of S6 kinase 1 (S6K1) and via inhibition of 4EBP1 (24, 25) and is sensitive to inhibition by rapamycin and rapalogs.”
BackgroundmTORC1 pathway in DNA damage response
Ma, Y., Vassetzky, Y., & Dokudovskaya, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.06.011 · Cited by 154
Lai, Z.-W., Borsuk, R., Shadakshari, A., Yu, J., Dawood, M., Garcia, R., Francis, L., Tily, H., Bartos, A., Faraone, S. V., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301005 · Cited by 155
“mTOR is also activated by oxidative stress (14), which is detectable in lupus T cells via increased pro-”
BackgroundAhmed, S. F., Deb, S., Paul, I., Chatterjee, A., Mandal, T., Chatterjee, U., & Ghosh, M. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.321083 · Cited by 149
“Nontargeting control shRNA was similarly constructed (46).”
Yalcin, S., Marinković, D., Mungamuri, S. K., Zhang, X., Tong, W., Sellers, R. S., & Ghaffari, S. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.292 · Cited by 159
“ROS-mediated amplification of mTOR signalling pathway is consistent with the redox modulation of the interaction of mTOR with its regulator raptor (Sarbassov and Sabatini, 2005) and its repression of oxidative stress in hematopoietic cells (Chen et al, 2008).”
Ahmed, M. U., Xu, J., & Xu, P. (2012) · Development · doi:10.1242/dev.071670 · Cited by 162
“10E; Table 2), co-expression of Sox2 shRNA (Sarbassov and Sabatini, 2005) only reduced the number of Neurod1+NF+ neurons induced by EYA1 and SIX1 or by BAF170, BRG1, EYA1 and SIX1 (Fig.”
BackgroundZhang, J., Honbo, N. Y., Goetzl, E. J., Chatterjee, K., Karliner, J. S., & Gray, M. O. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00587.2006 · Cited by 146
Skeletal Muscle Abnormalities in Heart Failure
Kinugawa, S., Takada, S., Matsushima, S., Okita, K., & Tsutsui, H. (2015) · International Heart Journal · doi:10.1536/ihj.15-108 · Cited by 135
Hypoxia-Induced Endothelial Proliferation Requires Both mTORC1 and mTORC2
Li, W., Petrimpol, M., Molle, K. D., Hall, M. N., Battegay, E. J., & Humar, R. (2007) · Circulation Research · doi:10.1161/01.res.0000253094.03023.3f · Cited by 137
Xie, K., Ryan, D. P., Pearson, B. L., Henzel, K. S., Neff, F., Vidal, R. O., Hennion, M., Lehmann, I., Schleif, M., Schröder, S., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707337115 · Cited by 134
“Chronic inflammatory changes (69, 70) and/or altered redox states (71), associated with mitochondrial dysfunction (72), could contribute to mTOR signaling abnormalities in aging and senescence.”
BackgroundPhospho-S6 ribosomal protein: a potential new predictive sarcoma marker for targeted mTOR therapy
Iwenofu, O. H., Lackman, R. D., Staddon, A. P., Goodwin, D. G., Haupt, H. M., & Brooks, J. S. (2007) · Modern Pathology · doi:10.1038/modpathol.3800995 · Cited by 137
“14 4E-BP1 is a translational repressor that negatively regulates eukaryotic initiation factor 4Es4G (eIF-4EsG) complex by modulating phosphorylation of the involved protein”
BackgroundOaks, Z., Winans, T., Caza, T., Fernandez, D., Liu, Y., Landas, S. K., Banki, K., & Perl, A. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39791 · Cited by 136
“(6) and outside the immune system (7).”
BackgroundAntioxidant metabolism regulates CD8+ T memory stem cell formation and antitumor immunity
Pilipow, K., Scamardella, E., Puccio, S., Gautam, S., De Paoli, F., Mazza, E. M. C., De Simone, G., Polletti, S., Buccilli, M., Zanon, V., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.122299 · Cited by 132
“Among these, increased signaling downstream of mTOR due to direct activation of S6K1 and HIF-1 α stabilization are observed in the presence of increased ROS (51), and we have shown that NAC has a generalized inhibitory effect on several pathways that are regulated by these molecules, including glycolysis, induction of…”
ERp57/GRP58: A protein with multiple functions
Turano, C., Gaucci, E., Grillo, C., & Chichiarelli, S. (2011) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-011-0022-z · Cited by 137
“mTORC1 was previously shown to be redox-regulated [ 65 ], and ERp57 can now be held responsible for this redox dependence [64].”
BackgroundMulti-mechanisms are involved in reactive oxygen species regulation of mTORC1 signaling
Li, M., Zhao, L., Liu, J., Liu, A., Jia, C., Ma, D., Jiang, Y., & Bai, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.015 · Cited by 139
Makhov, P. B., Golovine, K. V., Teper, E., Kutikov, A., Mehrazin, R., Corcoran, A., Tulin, A. V., Uzzo, R. G., & Kolenko, V. M. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.810 · Cited by 134
“Recent studies have shown that treatment with H2O2 and other oxidative agents increases the activation of Akt/mTOR signalling (Sarbassov and Sabatini, 2005; Li et al, 2010; Yoshida et al, 2011), whereas high doses of these agents have the reverse effect on mTORC1 activity (Kim et al, 2002; Liu et al, 2008; Li et al, 2…”
BackgroundThinking globally and acting locally with TOR
Arsham, A. M., & Neufeld, T. P. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.09.005 · Cited by 152
Floyd, S., Favre, C., Lasorsa, F. M., Leahy, M., Trigiante, G., Stroebel, P., Marx, A., Loughran, G., O'Callaghan, K., Marobbio, C. M. T., et al. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-12-1109 · Cited by 124
“S6K1 and 4EBP1 have previously been shown to be dephosphorylated in response to disruption of mitochondrial function (Kim et al., 2002) and the mTOR-raptor complex to be regulated in a redox-sensitive manner (Sarbassov and Sabatini, 2005).”
BackgroundSchwann cell autophagy counteracts the onset and chronification of neuropathic pain
Marinelli, S., Nazio, F., Tinari, A., Ciarlo, L., D'Amelio, M., Pieroni, L., Vacca, V., Urbani, A., Cecconi, F., Malorni, W., et al. (2014) · Pain · doi:10.1016/j.pain.2013.09.013 · Cited by 119
“Previous findings [49] demonstrated that the mTOR pathway and complex could be regulated by a redox-sensitive mechanism: mTOR may be the direct target of oxidizing agents.”
BackgroundVučetić, M., Cormerais, Y., Parks, S. K., & Pouysségur, J. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00319 · Cited by 111
“mTORC1 activation was also observed when cells were treated with oxidizing agents, and surprisingly, even in AA-depleted conditions (66, 67).”
BackgroundRajesh, K., Krishnamoorthy, J., Kazimierczak, U., Tenkerian, C., Papadakis, A. I., Wang, S., Huang, S., & Koromilas, A. E. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.554 · Cited by 136
Cysteine and obesity: consistency of the evidence across epidemiologic, animal and cellular studies
Elshorbagy, A. K., Kozich, V., Smith, A. D., & Refsum, H. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834d199f · Cited by 114
James, M. A. (2011) · Frontiers in bioscience · doi:10.2741/4022 · Cited by 111
“Autophagy as a mechanism for survival is regulated mainly through the mTOR network (42).”
BackgroundChoi, K., Kim, S., Ha, J., Kim, S., & Son, J. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06463.x · Cited by 108
Manzella, N., Santin, Y., Maggiorani, D., Martini, H., Douin‐Echinard, V., Passos, J. F., Lezoualc'h, F., Binda, C., Parini, A., & Mialet‐Perez, J. (2018) · Aging Cell · doi:10.1111/acel.12811 · Cited by 106
Jin, M., Fu, L., Liu, K., Tian, C., Wu, Z., Jung, Y., Ferreira, R. B., Carroll, K. S., Blackwell, T. K., & Yang, J. H. (2021) · Nature Communications · doi:10.1038/s41467-021-21686-3 · Cited by 107
Mitochondrial signaling, TOR, and life span
Schieke, S. M., & Finkel, T. (2006) · Biological Chemistry · doi:10.1515/bc.2006.170 · Cited by 106
Stem Cells, Redox Signaling, and Stem Cell Aging
Liang, R., & Ghaffari, S. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5300 · Cited by 106
“ROS also regulate mTOR directly by controlling the interaction of mTOR with mTOR regulator raptor (95, 128).”
Sending Out an SOS: Mitochondria as a Signaling Hub
Bohovych, I., & Khalimonchuk, O. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00109 · Cited by 103
Glycolytic inhibition as a strategy for developing calorie restriction mimetics
Ingram, D. K., & Roth, G. S. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.12.001 · Cited by 116
Inhibition of PI3K/AKT/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells
Hambright, H. G., Meng, P., Kumar, A. P., & Ghosh, R. (2015) · Oncotarget · doi:10.18632/oncotarget.3131 · Cited by 107
“The effect of ROS on mTORC1 is contextual [44].”
BackgroundMultifunctional molecule ERp57: From cancer to neurodegenerative diseases
Hettinghouse, A., Liu, R., & Liu, C.-J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.011 · Cited by 110
“A reduction in mTORC1 response to insulin in ERp57 knockdown cells indicates a role of ERp57 in upstream signal detection, probably through function in the redox-sensing mechanism ofmTOR (Ramirez-Rangel et al., 2011; Sarbassov & Sabatini, 2005).”
Regulation of CD8+ T memory and exhaustion by the mTOR signals
Chen, Y., Xu, Z., Sun, H., Ouyang, X., Han, Y., Yu, H., Wu, N., Xie, Y., & Su, B. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01064-3 · Cited by 105
FOXO3‐mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis
Zhang, X., Campreciós, G., Rimmelé, P., Liang, R. H.-S., Yalcin, S., Mungamuri, S. K., Barminko, J., d’Escamard, V., Baron, M. H., Brugnara, C., et al. (2014) · American Journal of Hematology · doi:10.1002/ajh.23786 · Cited by 103
“Given the function of mTOR protein kinase in cellular metabolism [34,35] and its sensitivity to redox modulation [48], in particular in erythroblast precursors (Fig.”
BackgroundResultScavenging reactive oxygen species inhibits status epilepticus-induced neuroinflammation
McElroy, P. B., Liang, L., Day, B. J., & Patel, M. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.009 · Cited by 100
“Ample evidence in the literature suggests that a redox-sensitive mechanism can regulate mTOR signaling whereby treatment with oxidizing agents can increase S6 phosphorylation and that with a reducing agent inhibits the process (Sarbassov and Sabatini, 2005).”
Spoden, G. A., Rostek, U., Lechner, S. G., Mitterberger, M. C., Mazurek, S., & Zwerschke, W. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.06.024 · Cited by 101
Aberrant mTOR activation in senescence and aging: A mitochondrial stress response?
Nacarelli, T., Azar, A., & Sell, C. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.11.004 · Cited by 94
“Although it is clear that high levels of stress or DNAdamage can serve to inhibitmTOR(Sengupta et al., 2010), redox regulation of mTOR has been observed in HEK293 cells following direct application of cellular oxidizing agents (Sarbassov and Sabatini, 2005).”
mTOR signaling networks: mechanistic insights and translational frontiers in disease therapeutics
Zhang, H., Xiao, X., Pan, Z., & Dokudovskaya, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02493-4 · Cited by 123
“308 Interestingly, low ROS levels can activate mTORC1 through the oxidation of cysteine residues in the mTORC1 complex itself 309 or in RHEB.”
Role of Inositol Trisphosphate Receptors in Autophagy in DT40 Cells
Khan, M. T., & Joseph, S. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114207 · Cited by 91
Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway
Iida, K., Naiki, T., Naiki‐Ito, A., Suzuki, S., Kato, H., Nozaki, S., Nagai, T., Etani, T., Nagayasu, Y., Ando, R., et al. (2020) · Cancer Science · doi:10.1111/cas.14334 · Cited by 91
Reactive Oxygen Species Regulation of Autophagy in Skeletal Muscles
Rahman, M., Mofarrahi, M., Kristof, A. S., Nkengfac, B., Harel, S., & Hussain, S. N. A. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5410 · Cited by 91
“Both AMPK and mTORC1 are well known to be under the influence of ROS (7, 41, 46).”
Role of Natural Radiosensitizers and Cancer Cell Radioresistance: An Update
Malik, A., Sultana, M., Qazi, A., Qazi, M. H., Parveen, G., Waquar, S., Ashraf, A. B., & Rasool, M. (2016) · Analytical Cellular Pathology · doi:10.1155/2016/6146595 · Cited by 88
“Themetabolic enzymes/proteins that direct the metabolic flux in nutrientsensing pathways can be modified directly by ROS [24–26].”
BackgroundA Role for p38 Stress-Activated Protein Kinase in Regulation of Cell Growth via TORC1
Cully, M., Genevet, A., Warne, P. H., Treins, C., Liu, T., Bastien, J., Baum, B., Tapon, N., Leevers, S. J., & Downward, J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00688-09 · Cited by 102
“Interestingly, chemical disruption of mitochondrial energetics (and therefore reduced ROS production) results in the dephosphorylation of TORC1 targets; this can be reversed by simultaneously treating cells with oxidizing compounds (61).”
BackgroundDuszka, K., Gregor, A., Guillou, H., König, J. S., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071708 · Cited by 90
Huang, N., Winans, T., Wyman, B., Oaks, Z., Faludi, T., Choudhary, G., Lai, Z., Lewis, J., Beckford, M., Duarte, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46441-2 · Cited by 92
“Inturn,blockadeofmTOR with rapamycin has shown preliminary evidence for remarkable ther-apeuticef fi cacy both inmice 12 – 14 and patients with SLE 5,15 – 17 . mTOR may be activated by oxidative stress 18,19 and localization to the lysosomal membranes where it senses amino acid suf fi ciency 20 .”
MethodGlover, E. I., Yasuda, N., Tarnopolsky, M. A., Abadi, A., & Phillips, S. M. (2010) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-137 · Cited by 81
mTORC1‐ and mTORC2‐interacting proteins keep their multifunctional partners focused
Bracho‐Valdés, I., Moreno‐Alvarez, P., Valencia‐Martínez, I., Robles‐Molina, E., Chávez‐Vargas, L., & Vázquez‐Prado, J. (2011) · IUBMB Life · doi:10.1002/iub.558 · Cited by 89
“The redox status of the cell impacts the activity of mTORC1 (8, 117).”
BackgroundHashemzaei, M., Heravi, R. E., Rezaee, R., Roohbakhsh, A., & Karimi, G. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.038 · Cited by 85
TOR Signaling Couples Oxygen Sensing to Lifespan in C. elegans
Schieber, M., & Chandel, N. S. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.075 · Cited by 79
“Oxidants in mammalian cells have also been shown to activate TOR signaling (Sarbassov and Sabatini, 2005).”
BackgroundGlutamate dehydrogenase contributes to leucine sensing in the regulation of autophagy
Lorin, S., Tol, M. J., Bauvy, C., Strijland, A., Poüs, C., Verhoeven, A. J., Codogno, P., & Meijer, A. J. (2013) · Autophagy · doi:10.4161/auto.24083 · Cited by 72
Mammalian TOR signaling to the AGC kinases
Su, B., & Jacinto, E. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.618113 · Cited by 85
Nistala, R., Habibi, J., Aroor, A., Sowers, J. R., Hayden, M. R., Meuth, A., Knight, W., Hancock, T., Klein, T., DeMarco, V. G., et al. (2014) · Obesity · doi:10.1002/oby.20833 · Cited by 79
“There is accumulating data suggesting that mTOR is redox-sensitive and the pathways that govern hypertrophy and hyperfiltration in obesity-related glomerulopathy are susceptible to oxidant injury (5, 6, 35, 36).”
BackgroundHać, A., Hofman, D., Konopa, G., & Herman-Antosiewicz, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.020 · Cited by 82
Powers, S. K., & Schrager, M. A. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102374 · Cited by 75
REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch
Miyazaki, M., & Esser, K. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00464.2008 · Cited by 66
“Myoblasts were incubated with serum/antibiotic-free DMEM or serum/antibiotic-free DMEM without leucine for 60 min, and leucine-depleted cells were restimulated with DMEM containing 50 g/ml leucine for 20 min (36).”
MethodChen, Z., Zhang, Y., Jia, C., Wang, Y., Lai, P., Zhou, X., Wang, Y., Song, Q., Lin, J., Ren, Z., et al. (2013) · Oncogene · doi:10.1038/onc.2013.402 · Cited by 71
Pancreatic β cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics
Hernández, M. G., García-Aguilar, A., Burillo, J., Gómez, R., Manca, M. A., Novials, A., Alcarraz‐Vizán, G., Guillén, C., & Benito, M. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0533-x · Cited by 70
Metabolic regulation of organelle homeostasis in lupus T cells
Caza, T. N., Talabér, G., & Perl, A. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.07.001 · Cited by 66
“Oxidative stress stimulates mTORC1 activity, with increased interaction of Raptor with mTOR and subsequent phosphorylation of S6 kinase in the presence of thiol oxidants [95].”
Metadata
- Authors
- Sarbassov, D. D., & Sabatini, D. M.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Sabatini, David M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 280
- Issue
- 47
- Pages
- 39505-39509
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2054943275
- Cited by
- 248
- References
- 32
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 6 · 2023: 11 · 2022: 7 · 2021: 16 · 2020: 14 · 2019: 6 · 2018: 12 · 2017: 21 · 2016: 13 · 2015: 15 · 2014: 12 · 2013: 16 · 2012: 12
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5448 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA103866, R01CA103866)
- National Institute of Allergy and Infectious Diseases (AI47389))
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- mTOR signaling, redox regulation, S6K1 phosphorylation, nutrient sensing, cell size control, diamide, phenylarsine oxide, BAL, nutrient deprivation, oxidative stress
- MeSH terms
- Regulatory-Associated Protein of mTOR, Arsenicals, Cell Line, Diamide, Dimercaprol, Humans, Oxidation-Reduction, Phosphorylation, Protein Kinases, Proteins, Recombinant Proteins, Transfection, Signal Transduction, Oxidants, RNA, Small Interfering, Ribosomal Protein S6 Kinases, 70-kDa, Multiprotein Complexes, Adaptor Proteins, Signal Transducing, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.